SEOUL, Aug. 10 (Korea Bizwire) — SK Biopharmaceuticals Co., a biopharmaceutical affiliate of SK Group, said Thursday its net loss narrowed in the second quarter from a year earlier thanks to stellar overseas sales of its flagship epilepsy medication. Its net deficit for the April-June period reached 23.3 billion won (US$17.7 million) on a consolidated [...]
SEOUL, Aug. 9 (Korea Bizwire) – SK bioscience Co., a pharmaceutical affiliate under South Korea’s SK Group, said Wednesday it has purchased 6.5 million shares in the U.S.-based biotechnology company Novavax Inc. for 110 billion won (US$83.4 million). With the stock purchase, SK bioscience will hold a 6.5 percent share in Novavax, according to the [...]
SEOUL, Aug. 8 (Korea Bizwire) — South Korea’s major IT companies are venturing into the non-face-to-face healthcare market in the latter half of this year. Local telecom giant KT Corp. finalized the trademark registration for KT MyCare, a remote care service catering to chronic conditions like diabetes, with the Korean Intellectual Property Office at the [...]
SEOUL, Aug. 2 (Korea Bizwire) — Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, has been in talks with Biogen Inc. to buy the U.S. biotech firm’s biosimilar business unit, industry sources said Wednesday. Through the deal with the Nasdaq-listed firm, Samsung Bioepis seeks to secure a direct sales network in the United [...]
SEOUL, July 18 (Korea Bizwire) — SK Biopharmaceuticals Co., a pharmaceutical affiliate of South Korea’s SK Group, said Tuesday that its signature anti-epilepsy treatment, Xcopri, could generate US$1 billion in sales in the United States in 2029. Xcopri, or cenobamate, is a medication for partial-onset seizures in adults discovered by SK Biopharmaceuticals and its U.S. [...]
SEOUL, July 10 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Monday it has signed a US$390.9 million deal with Novartis Pharma AG to manufacture the Switzerland-based pharmaceutical firm’s products. It is the final contract for an investment letter of intent announced in June last year, in which [...]
SEOUL, July 5 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate of South Korea’s SK Group, said Wednesday it has joined hands with Thailand’s state-run drugmaker to build vaccine manufacturing and development infrastructure in the Southeast Asian country. SK bioscience and Thailand’s Government Pharmaceutical Organization (GPO) signed a memorandum of understanding (MOU) on Tuesday, [...]
SEOUL, July 4 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Monday it has sealed a combined US$1.08 billion partnership contracts with U.S. pharmaceutical giant Pfizer so far this year. The Korean company said it signed a new contract with Pfizer, a follow-up to the bilateral deal set [...]
SEOUL, June 30 (Korea Bizwire) — SK Biopharmaceuticals announced on Friday its acquisition of 40 million shares of ProteoVant Sciences, a US-based research and development company, for 62 billion won (US$47 million). The purchase includes all shares held by Roivant Science, ProteoVant’s largest shareholder with a 60% stake. SK holdings, the parent company of SK [...]
SEOUL, June 23 (Korea Bizwire) — Kakao Healthcare, a digital healthcare unit of South Korean tech giant Kakao Corp., said Thursday it has signed a contract with the U.S. medical device company DexCom, Inc. to enhance collaboration in blood glucose management services. Both parties will offer digital blood glucose management services by leveraging their respective [...]